do you point out this company without sounding like...

do you point out this company without sounding like "over-hyping" NVGN ??

Good ex. of what these drug discovery companies can do, before even entering Phase 3. I always laugh when i see some who think NVGN won't see any pps appreciation, until Phase 3.....the end, of Phase 3. Especially when you can only sell & not buy NVGN, on-line through E-trade.

Keep in mind, Esperion is just a one trick-pony.

" Shares of Esperion closed Monday up 14.1% at $75.51 in its 52-week trading range of $15.00 to $120.96."

http://247wallst.com/healthcare-bus...tudy-and-keeps-volatility-traders-interested/

Glta!
Chris